Half-life of maternal labetalol in a premature infant
- 25 Downloads
Intra-uterine heart arrhythmia, postpartal respiratory insufficiency, bradycardia and hypoglycaemia were observed in a premature infant (37 weeks gestational age) delivered by a caesarian section. The mother had been treated with adequate doses of labetalol because of pregnancy-induced hypertension and her plasma concentration was found to be 89μg/1 one day after delivery. The half-life of labetalol in the plasma of the infant was found to be approximately 24 h,i.e. substantially longer than in normal adults. The half-life of labetalol in newborn premature infants may be prolonged as compared to normal adults. More studies are required regarding the pharmacokinetics of this agent in premature infants and newborn babies.
KeywordsHalf-life Infant, premature Labetalol Pharmacokinetics
Unable to display preview. Download preview PDF.
- 2.Lardoux H, Gerard J, Blazquez F, Chouty F, Flouvat B. Hypertension in pregnancy: evaluation of two beta blockers: atenolol and labetalol. Eur Heart J 1983;4 (Suppl G):35–40.Google Scholar
- 3.Riley A, Symonds EM, eds. The investigation of labetalol in the management of hypertension in pregnancy. Amsterdam: Excerpta Medica, 1982. (International congress series 591.)Google Scholar
- 5.Jouppila P, Kirkinen P, Koivula A, Ylikorkala O. Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in pre-eclampsia. Br J Obstet Gynecol 1986;93:543–7.Google Scholar
- 6.Woods DL, Malan AF. Side effects of labetalol in newborn infants. Br J Obstet Gynecol 1983;90:876.Google Scholar
- 7.Haraldsson A, Geven W. Severe adverse effects of maternal labetalol in premature infant. Acta Paediatr Scand (in press).Google Scholar
- 8.Martin LE, Hopkins R, Bland R. Metabolism of labetalol by animals and man. Br J Clin Pharmacol 1976; (Suppl):695–710.Google Scholar
- 13.Wood DL, Morell DR. Atenolol: side effects in a newborn infant. Br Med J 1982;285:691–2.Google Scholar
- 14.Dumez Y, Tchobroutsky C, Hornych H, Amiel-Tison C. Neonatal effects of maternal administration of acebutolol. Br Med J 1981;283:1077–9.Google Scholar
- 17.Dagbjartsson A, Karlsson K, Kjellmer I, Rosén KG. Maternal treatment with cardioselective beta-blocking agent — consequences for the ovine fetus during intermittent asphyxia. J Devel Physiol 1985;7:287–96.Google Scholar